Giannetti, Matthew P.
Article History
Received: 15 August 2025
Accepted: 6 March 2026
First Online: 14 March 2026
Declarations
:
: Dr. Giannetti reports other from Blueprint Medicines, other from Cogent Biosciences, other from Novartis, other from NemaGen, other from InmaGene, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: The authors declare no competing interests.